122 related articles for article (PubMed ID: 24389448)
1. EGFR mutation testing for squamous cell lung carcinoma.
Liam CK; Leow HR; Pang YK
J Thorac Oncol; 2013 Dec; 8(12):e114. PubMed ID: 24389448
[No Abstract] [Full Text] [Related]
2. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
3. [Significance of molecular technology in diagnosis and therapy of non-small-cell lung cancer].
Chen XX; Zhou CC
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):570-2. PubMed ID: 23157756
[No Abstract] [Full Text] [Related]
4. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
Tam IY; Chung LP; Suen WS; Wang E; Wong MC; Ho KK; Lam WK; Chiu SW; Girard L; Minna JD; Gazdar AF; Wong MP
Clin Cancer Res; 2006 Mar; 12(5):1647-53. PubMed ID: 16533793
[TBL] [Abstract][Full Text] [Related]
5. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
[TBL] [Abstract][Full Text] [Related]
6. Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
Chiu CH; Chou TY; Chiang CL; Tsai CM
Cancer Chemother Pharmacol; 2014 Oct; 74(4):661-5. PubMed ID: 25053390
[TBL] [Abstract][Full Text] [Related]
7. EGFR gene mutations: is it prognostic or predictive in surgically resected lung cancer?
Mitsudomi T; Tada H
J Thorac Oncol; 2012 Dec; 7(12):1739-1741. PubMed ID: 23154542
[No Abstract] [Full Text] [Related]
8. Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.
Zakowski MF; Rekhtman N; Auger M; Booth CN; Crothers B; Ghofrani M; Khalbuss W; Laucirica R; Moriarty AT; Tabatabai ZL; Barkan GA
Arch Pathol Lab Med; 2016 Oct; 140(10):1116-20. PubMed ID: 27552093
[TBL] [Abstract][Full Text] [Related]
9. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
10. Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms.
Leuzzi G; Cesario A; Vita ML; Parisi AM; Petrone G; Martini M; Rindi G; Granone P
J Thorac Oncol; 2012 May; 7(5):934-6. PubMed ID: 22722795
[No Abstract] [Full Text] [Related]
11. EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities.
da Cunha Santos G; Saieg MA; Geddie W; Leighl N
Cancer Cytopathol; 2011 Apr; 119(2):80-91. PubMed ID: 21400669
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of hotspot mutations in epidermal growth factor receptor by polymerase chain reaction facilitates the management of non-small cell lung cancer.
Hung KS; Lee CN; Liu HE
J Thorac Oncol; 2008 Oct; 3(10):1202-3. PubMed ID: 18827621
[No Abstract] [Full Text] [Related]
13. Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.
Wang Z; Shen Z; Li Z; Duan J; Fu S; Liu Z; Bai H; Zhang Z; Zhao J; Wang X; Wang J
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9990-5. PubMed ID: 26216950
[TBL] [Abstract][Full Text] [Related]
14. EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer.
Weber B; Hager H; Sorensen BS; McCulloch T; Mellemgaard A; Khalil AA; Nexo E; Meldgaard P
Lung Cancer; 2014 Feb; 83(2):224-30. PubMed ID: 24388704
[TBL] [Abstract][Full Text] [Related]
15. Tissue Is the Issue for Diagnosis of EGFR T790M Mutation.
Khan J; Pritchard CC; Martins RG
J Thorac Oncol; 2016 Jul; 11(7):e91-2. PubMed ID: 27339415
[No Abstract] [Full Text] [Related]
16. EGFR mutations detection on liquid-based cytology: is microscopy still necessary?
Malapelle U; de Rosa N; Bellevicine C; Rocco D; Vitiello F; Piantedosi FV; Illiano A; Nappi O; Troncone G
J Clin Pathol; 2012 Jun; 65(6):561-4. PubMed ID: 22466414
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
18. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer.
Cho WC
Expert Rev Mol Diagn; 2011 Nov; 11(8):763-6. PubMed ID: 22022936
[No Abstract] [Full Text] [Related]
19. Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers.
Chang YL; Wu CT; Shih JY; Lee YC
Ann Surg Oncol; 2011 Feb; 18(2):543-50. PubMed ID: 20811949
[TBL] [Abstract][Full Text] [Related]
20. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib.
Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K
Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
